Rom***PhD

Director of Business Development

学歴

University of Bern

University of Bern (2013 - 2016)

  • Degree: PhD in Immunology
  • Field of Study: Microbiology and Immunology
  • Description: Thesis title: "Application of systems vaccinology to the veterinary field using a Toll-like receptor ligand adjuvanted liposomal vaccine targeting antigen presenting cells"

Universität Bern (2012 - 2013)

  • Degree: Master of Science (M.Sc.)
  • Field of Study: Molecular Life Science
  • Description: Special qualification in Microbiology/Immunology Master thesis at Laboratory Spiez, Spiez, Switzerland: “Evaluation of Liposomal formulations for the delivery of siRNA in a Langat Virus in vitro model”

Universität Konstanz / University of Konstanz (2008 - 2011)

  • Degree: Bachelor of Science (B.Sc.)
  • Field of Study: Biological Sciences
  • Description: Thesis: Chair of Biochemical Pharmacology: “Interactions between LRH-1 and the Glucocorticoid Receptor”

スキル:

Immunology, Data Analysis, Project Management, Microbiology

職務経験:

Director of Business Development at Envisagenics

  • Location:
  • Duration: 2023-06 to Present
  • Description: Envisagenics was founded in 2014 as a spinout of Cold Spring Harbor Laboratory. Our mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence. We focus on the discovery of RNA therapeutics. Over 30 million people in the US suffer from genetic diseases or cancer that could be caused by mutations affecting RNA splicing. 370 human diseases are known to be caused by splicing errors, and more remain to be discovered. Our breakthrough technology, SpliceCore, is a cloud-based platform that is experimentally validated to predict drug targets and biomarkers through splicing discovery from RNA-seq data, using Artificial Intelligence. We are using our software to identify splicing errors causative of diseases, identify the right drug-targets and develop RNA therapeutics through partnerships and collaborations with Biopharma. Our in-silico RNA therapeutics discovery platform replaces expensive drug-target selection and lead design with efficient computer simulations, decreasing time, cost, and failure risk of drug development programs.

Business Development Director at Champions Oncology, Inc.

  • Location: Greater Boston
  • Duration: 2022-04 to 2023-05
  • Description:

Sr. Manager, Key Accounts at SIRION BIOTECH GmbH

  • Location: Boston, Massachusetts, United States
  • Duration: 2021-03 to 2022-04
  • Description: • Consulting on custom viral vector manufacturing and engineering for projects across therapeutic areas (gene therapy, cell therapy, oncology, vaccines): AAVs, Adenoviruses, Lentiviruses • Establishing and managing business development activities to build long-term scientific collaborations as well as driving licensing of existing intellectual property. • Identification of prospective clients and advancing them to key accounts through successful project management.

Key Account Manager at SIRION BIOTECH GmbH

  • Location: Boston, Massachusetts, United States
  • Duration: 2019-10 to 2021-02
  • Description:

Postdoctoral Research Fellow in Hematology/Oncology at Boston Children's Hospital at Harvard Medical School

  • Location: Großraum Boston und Umgebung
  • Duration: 2017-06 to 2019-09
  • Description: • Directed laboratory projects to analyze cell death in cancer and viral infection models including MCMV, Zika virus, myeloid leukemia, and hematopoiesis (T cell development). • Developed Flow-FISH pipeline to analyze telomere length from in vivo and ex vivo studies published in Cell Stem Cell. • Managed lab activities as interim lab manager and trained peers, junior staff and students on crucial laboratory techniques (e.g. cell culture, PBMC isolation, multicolor flow cytometry) and handling of rodents. • Coursework: Scientists Teaching Science Course – A Nine-week Pedagogy Course for Postdocs, Introduction into Network Medicine, Python for Life Scientists, Life Science Industries and Non-Academic Careers for PhDs.
AI履歴書分析

候補者インテリジェンスレポート

米国の採用ディレクターの視点からAI分析 — キャリアの継続性、成長軌道、および役職適合性を評価します。

キャリアの継続性とリスク評価

Employment GapLow

No detectable employment gaps; career history shows continuous progression since 2017.

Industry ConsistencyLow

Career blends academic training with increasing industry BD roles; transition from postdoc to biotech partnerships is common and aligns with current path.

Tenure StabilityMedium

Most roles are 1-2 years; while not uncommon in biotech BD, it suggests moderate turnover that could raise questions for longer-term commitments.

Education-Career MatchLow

PhD in immunology from University of Bern aligns with role focus in immunology, virology, and biotech partnerships; strong fit for the US biotech market.

キャリア成長カーブ

Postdoctoral Research Fellow in Hematology/Oncology Entry
Boston Children's Hospital / Harvard Medical School
2017-06 to 2019-09
Key Account Manager Lateral
SIRION BIOTECH GmbH
2019-10 to 2021-02
Sr. Manager, Key Accounts ↑ 昇進
SIRION BIOTECH GmbH
2021-03 to 2022-04
Business Development Director ↑ 昇進
Champions Oncology, Inc.
2022-04 to 2023-05
Director of Business Development Lateral
Envisagenics
2023-06 to Present
評価:Roman's career shows a clear, upward trajectory within biotech business development, expanding from research-to-BD foundations to executive-level leadership in partnering, licensing, and strategy. He appears ready for senior director-level roles or VP BD responsibilities in biotech/pharma, particularly with gene therapy, RNA therapeutics, or AI-enabled drug discovery platforms.

最適な役職(トップ5)

1

Vice President, Business Development – Biotech/Pharma96% 適合

Progressive BD leadership across multiple biotech companies, strong technical background in immunology/virology, and a global network; proven ability to drive partnership conversations and strategic deals.

2

Senior Director/Head of Strategic Partnerships – Immunology/Cancer Therapies93% 適合

Extensive BD experience with key accounts and licensing, plus domain depth in immunology and cell/gene therapy; aligns with large-scale partnership programs and cross-functional leadership.

3

Director/Head of Corporate Development – RNA Therapeutics / Gene Therapy89% 適合

Strong fit for in-licensing, M&A/disposition, and strategic alliances in RNA therapeutics and gene therapy; PhD-based scientific credibility complements BD leadership.

4

Global Partnerships Lead – Immunology/Oncology85% 適合

Global network and experience with cross-regional teams; capable of expanding international collaborations and co-development programs.

5

Director of Strategic Alliances – RNA Therapeutics / AI-Driven Drug Discovery82% 適合

Combination of BD execution and AI-enabled discovery platforms (like Envisagenics) makes him suitable for alliances and licensing in AI-driven therapeutics.

AI Recruiterを体験する

無料で始めましょう。ライバルに先を越されないでください。

AI駆動の採用ソリューションを活用して、採用プロセスを自動化し、時間コストの80%を削減している10,000社以上の企業に加わりましょう。

33%オフ、残り48時間のみ!
AIを無料で試す

24時間365日自動運用

AIを活用した候補者スクリーニング

地理的・時差の制限なく採用活動

パーソナライズされたインテリジェントコミュニケーション

候補者エンゲージメントの自動評価

あなたの採用スタイルをインテリジェントに模倣・再現

4ヶ月間の返金保証

LinkedInアカウントのセキュリティを確保